Literature DB >> 1874571

Human papillomavirus infection and other risk factors for cervical neoplasia: a case-control study.

E A Morrison1, G Y Ho, S H Vermund, G L Goldberg, A S Kadish, K F Kelley, R D Burk.   

Abstract

A case control design has been used to investigate risk factors associated with the development of cervical squamous intraepithelial lesions (SIL) in a population of urban women in which non-affluent minority groups were heavily represented. Eighty-five women with histologically confirmed SIL were compared to a control group of 70 cytologically normal women. HPV infection was determined using both Southern blot hybridization and polymerase chain reaction (PCR) amplification specific for HPV types 16, 18, and 33. When Southern blot was used to detect HPV, logistic regression analysis identified HPV infection (odds ratio (OR) = 17.9, 95% confidence interval (CI) = 6.2-51.6) and low educational achievement (OR = 3.4, 95% CI = 1.2-10.1) as major independent risk factors. When PCR was employed to detect HPV, the logistic regression model suggested that HPV infection (OR = 10.4, 95% CI = 3.6-30.4) and Hispanic ethnicity (OR = 5.0, 95% CI = 1.2-20.5) represented independent risk factors; low educational achievement and Black ethnicity were risk factors of borderline significance. PCR detection of simultaneous co-infection with more than one HPV type was associated with a very high risk of SIL (OR for one type = 7.2, 95% CI = 2.4-21.9; OR for greater than I type = 43.0, 95% CI = 6.9-266.6). Furthermore, increased viral load determined by either method carried an increased risk of disease. HPV infection with viral types previously reported to be related to neoplastic or dysplastic lesions carried the highest risk of SIL. The association of HPV detected by Southern blot and SIL in women less than 35 years old had an OR of 10.1, whereas in women greater than or equal to 35 the OR was 74.5 (p = 0.09 for homogeneity of ORs). We conclude that infection with HPV is the major risk factor for cervical SIL and suggest that targeted HPV screening of women over age 35 may represent an innovative strategy to detect women at high risk of cervical neoplasia.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1874571     DOI: 10.1002/ijc.2910490103

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  18 in total

1.  Comparison of ViraPap, Southern hybridization, and polymerase chain reaction methods for human papillomavirus identification in an epidemiological investigation of cervical cancer.

Authors:  E Guerrero; R W Daniel; F X Bosch; X Castellsagué; N Muñoz; M Gili; P Viladiu; C Navarro; M L Zubiri; N Ascunce
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

2.  Evaluation of different techniques for identification of human papillomavirus types of low prevalence.

Authors:  Ivan Sabol; Martina Salakova; Jana Smahelova; Michal Pawlita; Markus Schmitt; Nina Milutin Gasperov; Magdalena Grce; Ruth Tachezy
Journal:  J Clin Microbiol       Date:  2008-03-05       Impact factor: 5.948

3.  Human papillomavirus type 16 sequence variants: identification by E6 and L1 lineage-specific hybridization.

Authors:  C M Wheeler; T Yamada; A Hildesheim; S A Jenison
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

4.  High prevalence of human papillomavirus infections in urine samples from human immunodeficiency virus-infected men.

Authors:  Paul H M Smits; Remco Bakker; Eefje Jong; Jan Willem Mulder; Pieter L Meenhorst; Bernhard Kleter; Leen-Jan van Doorn; Wim G V Quint
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

5.  PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems.

Authors:  W Qu; G Jiang; Y Cruz; C J Chang; G Y Ho; R S Klein; R D Burk
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

Review 6.  Replication and assembly of human papillomaviruses.

Authors:  M J Conway; C Meyers
Journal:  J Dent Res       Date:  2009-04       Impact factor: 6.116

7.  Polymerase chain reaction detection of human papillomavirus: quantitation may improve clinical utility.

Authors:  E A Morrison; G L Goldberg; A S Kadish; R D Burk
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

8.  Epidemiologic modeling of cervical dysplasia with molecular and cytopathological markers.

Authors:  Michael E Scheurer; Martial Guillaud; Guillermo Tortolero-Luna; Michele Follen; Karen Adler-Storthz
Journal:  Gynecol Oncol       Date:  2007-08-29       Impact factor: 5.482

Review 9.  Anogenital human papillomavirus infection. Changes in understanding and management.

Authors:  J W Sellors; C Law
Journal:  Can Fam Physician       Date:  1994-01       Impact factor: 3.275

10.  High-risk and multiple human papillomavirus (HPV) infections in cancer-free Jamaican women.

Authors:  Angela Watt; David Garwood; Maria Jackson; Novie Younger; Camille Ragin; Monica Smikle; Horace Fletcher; Norma McFarlane-Anderson
Journal:  Infect Agent Cancer       Date:  2009-02-10       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.